Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Nader Z. Pourhassan, PhD, the former CEO of CytoDyn, was sentenced yesterday to ...
When Elon Musk was at Davos last week, an interviewer asked him if he thought ag...
A new survey found that most physicians are open to using AI, but they’re unhapp...
Early-career physicians committed to advancing drivers of health are invited to ...
With a trio of partnership announcements this month, 10x Genomics has signaled i...
AI‑designed anti‑CRISPR inhibitors rapidly block Cas13 activity and may offer a ...
Bacterial biofilms have been discovered embedded within the most common kidney s...
Studying chaperone proteins in the fruit fly, researchers report what they say i...
The collaboration is designed to accelerate clinical translation and support sca...
The Golden Gate platform engineers bacteriophages synthetically using sequence d...
According to the report, Qiagen “has held talks with several possible buyers in ...
Experimental CAR T cell immunotherapy targeting tumor-associated macrophages pro...
Scientists tested kaempferol, a natural compound found in vegetables like kale a...
A link between increased colorectal cancer risk and inflammatory bowel disease i...
Individuals with Down syndrome experience significant alterations in liver metab...
The post Breaking Down the 2026 PRITE Blueprint appeared first on BoardVitals Blog.
